Evoke Pharma Inc reports results for the quarter ended in December - Earnings Summary

Evoke Pharma

21/03/2023 21:01

* Evoke Pharma Inc  EVOK.OQ  reported a quarterly adjusted
loss
of 53 cents​​ per share for the quarter ended in December. The
lone analyst forecast for the quarter was for a loss of 53 cents
per share.
    * Revenue rose 121.1% to $796.00 thousand from a year ago;
analysts expected $889.00 thousand. 
    * Evoke Pharma Inc's reported EPS for the quarter was a loss
of 53
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Evoke Pharma Inc shares had risen by 8.6% this quarter.
    * The company reported a quarterly loss of $1.8 million.
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 21 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.53          -0.53          Met
 Sep. 30 2022      -0.66          -0.60          Beat
 Jun. 30 2022      -0.60          -0.71          Missed
 Mar. 31 2022      -0.48          -0.84          Missed